A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.
In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...
Haryana launches a strengthened framework under the National Viral Hepatitis Control Programme, focusing on enforceable reporting, integrated digital surveillance, maternal and high-risk group ...
A Norwich woman has spoken out for the first time about the guilt she feels after surviving Hepatitis C contracted through.
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...
Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...
Hepatitis occurs when different viruses cause inflammation of the liver. Hepatitis A (HAV) and hepatitis E (HEV) viruses are mainly spread through contaminated food or water and typically cause ...
1don MSNOpinion
Opinion: Will the Senate learn from its mistakes on Trump’s surgeon general nomination?
Means’s testimony provides abundant evidence that confirming her as the government’s leading spokesperson on public health ...
Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results